Lag of Accommodation With DOT Spectacle Lenses

NCT04700111•SightGlass Vision, Inc.

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Myopia, Myopia Progression, Lag of Accommodation, Hyperopic Retinal Blur, Reduction in Contrast

Interventions

DOT Pattern

Control Spectacles

Locations

Canada

Locations (1)

Centre for Ocular Research and Education

Waterloo, Ontario, Canada

Key Dates

Start Date

February 1, 2022

Primary Completion Date

June 9, 2022

Completion Date

March 31, 2026

Last Updated

December 20, 2024

Sponsors

Lead Sponsor

SightGlass Vision, Inc.

Collaborators

University of Waterloo

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 20, 2024Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions